Adcentrx Therapeutics
Joseph Shan possesses extensive experience in clinical operations and research within the biopharmaceutical sector. Currently serving as Vice President of Clinical Operations at Adcentrx Therapeutics, Joseph has previously held senior positions such as VP of Clinical Research and Head of Clinical Operations at Mosaic ImmunoEngineering Inc., and Executive Director of Clinical Development Operations at both MEI Pharma and Elevar Therapeutics. Additionally, Joseph has worked as an Independent Consultant specializing in clinical operations and development. Joseph's academic credentials include a Master of Public Health with a focus on Epidemiology from The George Washington University School of Medicine and Health Sciences and a Bachelor of Science in Physiological Sciences from UCLA.
Adcentrx Therapeutics
1 followers
Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease-fighting power of small-molecule payloads, Adcentrx strives to develop next-generation targeted therapies for improving patient treatment options.